APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin Like Growth Factor I

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Insulin Like Growth Factor I Industry Growth and Trends Forecast to 2032

19 December 202578 pages

Choose your research edition.

Industry ResearchInsulin Like Growth Factor I Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Like Growth Factor I Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Insulin Like Growth Factor I Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Like Growth Factor I Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Like Growth Factor I Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Insulin Like Growth Factor I market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Insulin Like Growth Factor I is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Insulin Like Growth Factor I is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Insulin Like Growth Factor I is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Insulin Like Growth Factor I include Regulaxis SAS, MedImmune LLC, Genervon Biopharmaceuticals LLC and Boehringer Ingelheim GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Insulin Like Growth Factor I market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Insulin Like Growth Factor I market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Insulin Like Growth Factor I market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Insulin Like Growth Factor I.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Insulin Like Growth Factor I market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Insulin Like Growth Factor I Market by Company

Regulaxis SAS

MedImmune LLC

Genervon Biopharmaceuticals LLC

Boehringer Ingelheim GmbH

Insulin Like Growth Factor I Segment by Type

CIGB-845

Dusigitumab

M-630

M-610.27

GM-6

Others

Insulin Like Growth Factor I Segment by Application

Breast Cancer

Muscular Dystrophy

Huntington Disease

Alzheimer's Disease

Others

Insulin Like Growth Factor I Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Like Growth Factor I market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Like Growth Factor I and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Like Growth Factor I.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insulin Like Growth Factor I manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Insulin Like Growth Factor I in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of CIGB-845 Table 2. Major Company of Dusigitumab Table 3. Major Company of M-630 Table 4. Major Company of M-610.27 Table 5. Major Company of GM-6 Table 6. Major Company of Others Table 7. Global Insulin Like Growth Factor I Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Insulin Like Growth Factor I Sales by Type (2021-2026) & (W Units) Table 9. Global Insulin Like Growth Factor I Sales Market Share in Volume by Type (2021-2026) Table 10. Global Insulin Like Growth Factor I Sales by Type (2021-2026) & (US$ Million) Table 11. Global Insulin Like Growth Factor I Sales Market Share in Value by Type (2021-2026) Table 12. Global Insulin Like Growth Factor I Price by Type (2021-2026) & (US$/Unit) Table 13. Global Insulin Like Growth Factor I Sales by Type (2027-2032) & (W Units) Table 14. Global Insulin Like Growth Factor I Sales Market Share in Volume by Type (2027-2032) Table 15. Global Insulin Like Growth Factor I Sales by Type (2027-2032) & (US$ Million) Table 16. Global Insulin Like Growth Factor I Sales Market Share in Value by Type (2027-2032) Table 17. Global Insulin Like Growth Factor I Price by Type (2027-2032) & (US$/Unit) Table 18. North America Insulin Like Growth Factor I Sales by Type (2021-2026) & (W Units) Table 19. North America Insulin Like Growth Factor I Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Insulin Like Growth Factor I Sales by Type (2021-2026) & (W Units) Table 21. Europe Insulin Like Growth Factor I Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Insulin Like Growth Factor I Sales by Type (2021-2026) & (W Units) Table 23. Asia-Pacific Insulin Like Growth Factor I Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Insulin Like Growth Factor I Sales by Type (2021-2026) & (W Units) Table 25. Latin America Insulin Like Growth Factor I Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Insulin Like Growth Factor I Sales by Type (2021-2026) & (W Units) Table 27. Middle East and Africa Insulin Like Growth Factor I Sales by Type (2021-2026) & (US$ Million) Table 28. Insulin Like Growth Factor I Industry Trends Table 29. Insulin Like Growth Factor I Industry Drivers Table 30. Insulin Like Growth Factor I Industry Opportunities and Challenges Table 31. Insulin Like Growth Factor I Industry Restraints Table 32. Global Insulin Like Growth Factor I Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Insulin Like Growth Factor I Revenue Market Share by Company (2021-2026) Table 34. Global Insulin Like Growth Factor I Sales by Company (2021-2026) & (W Units) Table 35. Global Insulin Like Growth Factor I Sales Share by Company (2021-2026) Table 36. Global Insulin Like Growth Factor I Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Insulin Like Growth Factor I Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Insulin Like Growth Factor I Major Company Production Sites and Headquarters Table 39. Global Insulin Like Growth Factor I Company, Product Type & Application Table 40. Global Insulin Like Growth Factor I Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Insulin Like Growth Factor I by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Insulin Like Growth Factor I Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Insulin Like Growth Factor I Sales by Region (2021-2026) & (W Units) Table 45. Global Insulin Like Growth Factor I Sales Market Share in Volume by Region (2021-2026) Table 46. Global Insulin Like Growth Factor I Sales by Region (2021-2026) & (US$ Million) Table 47. Global Insulin Like Growth Factor I Sales Market Share in Value by Region (2021-2026) Table 48. Global Insulin Like Growth Factor I Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Insulin Like Growth Factor I Sales by Region (2027-2032) & (W Units) Table 50. Global Insulin Like Growth Factor I Sales Market Share in Volume by Region (2027-2032) Table 51. Global Insulin Like Growth Factor I Sales by Region (2027-2032) & (US$ Million) Table 52. Global Insulin Like Growth Factor I Sales Market Share in Value by Region (2027-2032) Table 53. Global Insulin Like Growth Factor I Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Insulin Like Growth Factor I Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Insulin Like Growth Factor I Sales by Application (2021-2026) & (W Units) Table 56. Global Insulin Like Growth Factor I Sales Market Share in Volume by Application (2021-2026) Table 57. Global Insulin Like Growth Factor I Sales by Application (2021-2026) & (US$ Million) Table 58. Global Insulin Like Growth Factor I Sales Market Share in Value by Application (2021-2026) Table 59. Global Insulin Like Growth Factor I Price by Application (2021-2026) & (US$/Unit) Table 60. Global Insulin Like Growth Factor I Sales by Application (2027-2032) & (W Units) Table 61. Global Insulin Like Growth Factor I Sales Market Share in Volume by Application (2027-2032) Table 62. Global Insulin Like Growth Factor I Sales by Application (2027-2032) & (US$ Million) Table 63. Global Insulin Like Growth Factor I Sales Market Share in Value by Application (2027-2032) Table 64. Global Insulin Like Growth Factor I Price by Application (2027-2032) & (US$/Unit) Table 65. North America Insulin Like Growth Factor I Sales by Application (2021-2026) & (W Units) Table 66. North America Insulin Like Growth Factor I Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Insulin Like Growth Factor I Sales by Application (2021-2026) & (W Units) Table 68. Europe Insulin Like Growth Factor I Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Insulin Like Growth Factor I Sales by Application (2021-2026) & (W Units) Table 70. Asia-Pacific Insulin Like Growth Factor I Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Insulin Like Growth Factor I Sales by Application (2021-2026) & (W Units) Table 72. Latin America Insulin Like Growth Factor I Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Insulin Like Growth Factor I Sales by Application (2021-2026) & (W Units) Table 74. Middle East and Africa Insulin Like Growth Factor I Sales by Application (2021-2026) & (US$ Million) Table 75. Regulaxis SAS Company Information Table 76. Regulaxis SAS Business Overview Table 77. Regulaxis SAS Insulin Like Growth Factor I Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Regulaxis SAS Insulin Like Growth Factor I Product Portfolio Table 79. Regulaxis SAS Recent Development Table 80. MedImmune LLC Company Information Table 81. MedImmune LLC Business Overview Table 82. MedImmune LLC Insulin Like Growth Factor I Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. MedImmune LLC Insulin Like Growth Factor I Product Portfolio Table 84. MedImmune LLC Recent Development Table 85. Genervon Biopharmaceuticals LLC Company Information Table 86. Genervon Biopharmaceuticals LLC Business Overview Table 87. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Product Portfolio Table 89. Genervon Biopharmaceuticals LLC Recent Development Table 90. Boehringer Ingelheim GmbH Company Information Table 91. Boehringer Ingelheim GmbH Business Overview Table 92. Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Boehringer Ingelheim GmbH Insulin Like Growth Factor I Product Portfolio Table 94. Boehringer Ingelheim GmbH Recent Development Table 95. North America Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 96. North America Insulin Like Growth Factor I Sales by Country (2021-2026) & (W Units) Table 97. North America Insulin Like Growth Factor I Sales Market Share by Country (2021-2026) Table 98. North America Insulin Like Growth Factor I Sales Forecast by Country (2027-2032) & (W Units) Table 99. North America Insulin Like Growth Factor I Sales Market Share Forecast by Country (2027-2032) Table 100. North America Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 101. North America Insulin Like Growth Factor I Market Size by Country (2021-2026) & (US$ Million) Table 102. North America Insulin Like Growth Factor I Market Share by Country (2021-2026) Table 103. North America Insulin Like Growth Factor I Market Size Forecast by Country (2027-2032) & (US$ Million) Table 104. North America Insulin Like Growth Factor I Market Share Forecast by Country (2027-2032) Table 105. Europe Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 106. Europe Insulin Like Growth Factor I Sales by Country (2021-2026) & (W Units) Table 107. Europe Insulin Like Growth Factor I Sales Market Share by Country (2021-2026) Table 108. Europe Insulin Like Growth Factor I Sales Forecast by Country (2027-2032) & (W Units) Table 109. Europe Insulin Like Growth Factor I Sales Market Share Forecast by Country (2027-2032) Table 110. Europe Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 111. Europe Insulin Like Growth Factor I Market Size by Country (2021-2026) & (US$ Million) Table 112. Europe Insulin Like Growth Factor I Market Share by Country (2021-2026) Table 113. Europe Insulin Like Growth Factor I Market Size Forecast by Country (2027-2032) & (US$ Million) Table 114. Europe Insulin Like Growth Factor I Market Share Forecast by Country (2027-2032) Table 115. Asia-Pacific Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 116. Asia-Pacific Insulin Like Growth Factor I Sales by Country (2021-2026) & (W Units) Table 117. Asia-Pacific Insulin Like Growth Factor I Sales Market Share by Country (2021-2026) Table 118. Asia-Pacific Insulin Like Growth Factor I Sales Forecast by Country (2027-2032) & (W Units) Table 119. Asia-Pacific Insulin Like Growth Factor I Sales Market Share Forecast by Country (2027-2032) Table 120. Asia-Pacific Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 121. Asia-Pacific Insulin Like Growth Factor I Market Size by Country (2021-2026) & (US$ Million) Table 122. Asia-Pacific Insulin Like Growth Factor I Market Share by Country (2021-2026) Table 123. Asia-Pacific Insulin Like Growth Factor I Market Size Forecast by Country (2027-2032) & (US$ Million) Table 124. Asia-Pacific Insulin Like Growth Factor I Market Share Forecast by Country (2027-2032) Table 125. Latin America Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 126. Latin America Insulin Like Growth Factor I Sales by Country (2021-2026) & (W Units) Table 127. Latin America Insulin Like Growth Factor I Sales Market Share by Country (2021-2026) Table 128. Latin America Insulin Like Growth Factor I Sales Forecast by Country (2027-2032) & (W Units) Table 129. Latin America Insulin Like Growth Factor I Sales Market Share Forecast by Country (2027-2032) Table 130. Latin America Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. Latin America Insulin Like Growth Factor I Market Size by Country (2021-2026) & (US$ Million) Table 132. Latin America Insulin Like Growth Factor I Market Share by Country (2021-2026) Table 133. Latin America Insulin Like Growth Factor I Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. Latin America Insulin Like Growth Factor I Market Share Forecast by Country (2027-2032) Table 135. Middle East and Africa Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 136. Middle East and Africa Insulin Like Growth Factor I Sales by Country (2021-2026) & (W Units) Table 137. Middle East and Africa Insulin Like Growth Factor I Sales Market Share by Country (2021-2026) Table 138. Middle East and Africa Insulin Like Growth Factor I Sales Forecast by Country (2027-2032) & (W Units) Table 139. Middle East and Africa Insulin Like Growth Factor I Sales Market Share Forecast by Country (2027-2032) Table 140. Middle East and Africa Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Middle East and Africa Insulin Like Growth Factor I Market Size by Country (2021-2026) & (US$ Million) Table 142. Middle East and Africa Insulin Like Growth Factor I Market Share by Country (2021-2026) Table 143. Middle East and Africa Insulin Like Growth Factor I Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Middle East and Africa Insulin Like Growth Factor I Market Share Forecast by Country (2027-2032) Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. Insulin Like Growth Factor I Distributors List Table 148. Insulin Like Growth Factor I Customers List Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Insulin Like Growth Factor I Image Figure 2. Global Insulin Like Growth Factor I Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Like Growth Factor I Market Size (2021-2032) & (US$ Million) Figure 4. Global Insulin Like Growth Factor I Sales (2021-2032) & (W Units) Figure 5. CIGB-845 Image Figure 6. Global CIGB-845 Sales YoY Growth (2021-2032) & (W Units) Figure 7. Dusigitumab Image Figure 8. Global Dusigitumab Sales YoY Growth (2021-2032) & (W Units) Figure 9. M-630 Image Figure 10. Global M-630 Sales YoY Growth (2021-2032) & (W Units) Figure 11. M-610.27 Image Figure 12. Global M-610.27 Sales YoY Growth (2021-2032) & (W Units) Figure 13. GM-6 Image Figure 14. Global GM-6 Sales YoY Growth (2021-2032) & (W Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 17. Global Insulin Like Growth Factor I Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Insulin Like Growth Factor I Market Share by Type 2025 VS 2032 Figure 19. North America Insulin Like Growth Factor I Sales Market Share in Volume by Type in 2025 Figure 20. North America Insulin Like Growth Factor I Sales Market Share in Value by Type in 2025 Figure 21. Europe Insulin Like Growth Factor I Sales Market Share in Volume by Type in 2025 Figure 22. Europe Insulin Like Growth Factor I Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Insulin Like Growth Factor I Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Insulin Like Growth Factor I Sales Market Share in Value by Type in 2025 Figure 25. Latin America Insulin Like Growth Factor I Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Insulin Like Growth Factor I Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Insulin Like Growth Factor I Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Insulin Like Growth Factor I Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Insulin Like Growth Factor I Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Breast Cancer Image Figure 32. Global Breast Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 33. Muscular Dystrophy Image Figure 34. Global Muscular Dystrophy Sales YoY Growth (2021-2032) & (W Units) Figure 35. Huntington Disease Image Figure 36. Global Huntington Disease Sales YoY Growth (2021-2032) & (W Units) Figure 37. Alzheimer's Disease Image Figure 38. Global Alzheimer's Disease Sales YoY Growth (2021-2032) & (W Units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 41. Global Insulin Like Growth Factor I Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Insulin Like Growth Factor I Market Share by Application 2025 VS 2032 Figure 43. North America Insulin Like Growth Factor I Sales Market Share in Volume by Application in 2025 Figure 44. North America Insulin Like Growth Factor I Sales Market Share in Value by Application in 2025 Figure 45. Europe Insulin Like Growth Factor I Sales Market Share in Volume by Application in 2025 Figure 46. Europe Insulin Like Growth Factor I Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Insulin Like Growth Factor I Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Insulin Like Growth Factor I Sales Market Share in Value by Application in 2025 Figure 49. Latin America Insulin Like Growth Factor I Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Insulin Like Growth Factor I Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Insulin Like Growth Factor I Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Insulin Like Growth Factor I Sales Market Share in Value by Application in 2025 Figure 53. North America Insulin Like Growth Factor I Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. North America Insulin Like Growth Factor I Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Insulin Like Growth Factor I Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Insulin Like Growth Factor I Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Insulin Like Growth Factor I Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Europe Insulin Like Growth Factor I Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Insulin Like Growth Factor I Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Insulin Like Growth Factor I Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Insulin Like Growth Factor I Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Asia-Pacific Insulin Like Growth Factor I Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Insulin Like Growth Factor I Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Insulin Like Growth Factor I Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Insulin Like Growth Factor I Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 66. Latin America Insulin Like Growth Factor I Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Insulin Like Growth Factor I Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Insulin Like Growth Factor I Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Insulin Like Growth Factor I Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 70. Middle East and Africa Insulin Like Growth Factor I Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Insulin Like Growth Factor I Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Insulin Like Growth Factor I Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Insulin Like Growth Factor I Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Insulin Like Growth Factor I Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • CIGB-845
  • Dusigitumab
  • M-630
  • M-610.27
  • GM-6
  • Others
Applications
  • Breast Cancer
  • Muscular Dystrophy
  • Huntington Disease
  • Alzheimer's Disease
  • Others
Companies covered
  • Regulaxis SAS
  • MedImmune LLC
  • Genervon Biopharmaceuticals LLC
  • Boehringer Ingelheim GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insulin Like Growth Factor I Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Insulin Like Growth Factor I Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Insulin Like Growth Factor I Market by Type
  6. 1.3.1 CIGB-845
  7. 1.3.2 Dusigitumab
  8. 1.3.3 M-630
  9. 1.3.4 M-610.27
  10. 1.3.5 GM-6
  11. 1.3.6 Others
  12. 1.4 Global Insulin Like Growth Factor I Market Size by Type
  13. 1.4.1 Global Insulin Like Growth Factor I Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Insulin Like Growth Factor I Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Insulin Like Growth Factor I Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Insulin Like Growth Factor I Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Insulin Like Growth Factor I Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Insulin Like Growth Factor I Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Insulin Like Growth Factor I Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Insulin Like Growth Factor I Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Insulin Like Growth Factor I Industry Trends
  2. 2.2 Insulin Like Growth Factor I Industry Drivers
  3. 2.3 Insulin Like Growth Factor I Industry Opportunities and Challenges
  4. 2.4 Insulin Like Growth Factor I Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Insulin Like Growth Factor I Revenue (2021-2026)
  2. 3.2 Global Top Players by Insulin Like Growth Factor I Sales (2021-2026)
  3. 3.3 Global Top Players by Insulin Like Growth Factor I Price (2021-2026)
  4. 3.4 Global Insulin Like Growth Factor I Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insulin Like Growth Factor I Major Company Production Sites & Headquarters
  6. 3.6 Global Insulin Like Growth Factor I Company, Product Type & Application
  7. 3.7 Global Insulin Like Growth Factor I Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insulin Like Growth Factor I Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insulin Like Growth Factor I Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insulin Like Growth Factor I Tier 1, Tier 2, and Tier 3
4 Insulin Like Growth Factor I Regional Status and Outlook
  1. 4.1 Global Insulin Like Growth Factor I Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Insulin Like Growth Factor I Historic Market Size by Region
  3. 4.2.1 Global Insulin Like Growth Factor I Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Insulin Like Growth Factor I Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Insulin Like Growth Factor I Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Insulin Like Growth Factor I Forecasted Market Size by Region
  7. 4.3.1 Global Insulin Like Growth Factor I Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Insulin Like Growth Factor I Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Insulin Like Growth Factor I Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Insulin Like Growth Factor I by Application
  1. 5.1 Insulin Like Growth Factor I Market by Application
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Muscular Dystrophy
  4. 5.1.3 Huntington Disease
  5. 5.1.4 Alzheimer's Disease
  6. 5.1.5 Others
  7. 5.2 Global Insulin Like Growth Factor I Market Size by Application
  8. 5.2.1 Global Insulin Like Growth Factor I Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Insulin Like Growth Factor I Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Insulin Like Growth Factor I Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Insulin Like Growth Factor I Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Insulin Like Growth Factor I Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Insulin Like Growth Factor I Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Insulin Like Growth Factor I Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Insulin Like Growth Factor I Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Regulaxis SAS
  2. 6.1.1 Regulaxis SAS Company Information
  3. 6.1.2 Regulaxis SAS Business Overview
  4. 6.1.3 Regulaxis SAS Insulin Like Growth Factor I Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Regulaxis SAS Insulin Like Growth Factor I Product Portfolio
  6. 6.1.5 Regulaxis SAS Recent Developments
  7. 6.2 MedImmune LLC
  8. 6.2.1 MedImmune LLC Company Information
  9. 6.2.2 MedImmune LLC Business Overview
  10. 6.2.3 MedImmune LLC Insulin Like Growth Factor I Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 MedImmune LLC Insulin Like Growth Factor I Product Portfolio
  12. 6.2.5 MedImmune LLC Recent Developments
  13. 6.3 Genervon Biopharmaceuticals LLC
  14. 6.3.1 Genervon Biopharmaceuticals LLC Company Information
  15. 6.3.2 Genervon Biopharmaceuticals LLC Business Overview
  16. 6.3.3 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Product Portfolio
  18. 6.3.5 Genervon Biopharmaceuticals LLC Recent Developments
  19. 6.4 Boehringer Ingelheim GmbH
  20. 6.4.1 Boehringer Ingelheim GmbH Company Information
  21. 6.4.2 Boehringer Ingelheim GmbH Business Overview
  22. 6.4.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Product Portfolio
  24. 6.4.5 Boehringer Ingelheim GmbH Recent Developments
7 North America by Country
  1. 7.1 North America Insulin Like Growth Factor I Sales by Country
  2. 7.1.1 North America Insulin Like Growth Factor I Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Insulin Like Growth Factor I Sales by Country (2021-2026)
  4. 7.1.3 North America Insulin Like Growth Factor I Sales Forecast by Country (2027-2032)
  5. 7.2 North America Insulin Like Growth Factor I Market Size by Country
  6. 7.2.1 North America Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Insulin Like Growth Factor I Market Size by Country (2021-2026)
  8. 7.2.3 North America Insulin Like Growth Factor I Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Insulin Like Growth Factor I Sales by Country
  2. 8.1.1 Europe Insulin Like Growth Factor I Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Insulin Like Growth Factor I Sales by Country (2021-2026)
  4. 8.1.3 Europe Insulin Like Growth Factor I Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Insulin Like Growth Factor I Market Size by Country
  6. 8.2.1 Europe Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Insulin Like Growth Factor I Market Size by Country (2021-2026)
  8. 8.2.3 Europe Insulin Like Growth Factor I Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Insulin Like Growth Factor I Sales by Country
  2. 9.1.1 Asia-Pacific Insulin Like Growth Factor I Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Insulin Like Growth Factor I Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Insulin Like Growth Factor I Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Insulin Like Growth Factor I Market Size by Country
  6. 9.2.1 Asia-Pacific Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Insulin Like Growth Factor I Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Insulin Like Growth Factor I Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Insulin Like Growth Factor I Sales by Country
  2. 10.1.1 South America Insulin Like Growth Factor I Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Insulin Like Growth Factor I Sales by Country (2021-2026)
  4. 10.1.3 South America Insulin Like Growth Factor I Sales Forecast by Country (2027-2032)
  5. 10.2 South America Insulin Like Growth Factor I Market Size by Country
  6. 10.2.1 South America Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Insulin Like Growth Factor I Market Size by Country (2021-2026)
  8. 10.2.3 South America Insulin Like Growth Factor I Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Insulin Like Growth Factor I Sales by Country
  2. 11.1.1 Middle East and Africa Insulin Like Growth Factor I Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Insulin Like Growth Factor I Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Insulin Like Growth Factor I Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Insulin Like Growth Factor I Market Size by Country
  6. 11.2.1 Middle East and Africa Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Insulin Like Growth Factor I Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Insulin Like Growth Factor I Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Insulin Like Growth Factor I Value Chain Analysis
  2. 12.1.1 Insulin Like Growth Factor I Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Insulin Like Growth Factor I Production Mode & Process
  7. 12.2 Insulin Like Growth Factor I Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Insulin Like Growth Factor I Distributors
  10. 12.2.3 Insulin Like Growth Factor I Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst